4//SEC Filing
Babu Yarlagadda S 4
Accession 0001127602-19-035551
CIK 0000882796other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:52 PM ET
Size
5.1 KB
Accession
0001127602-19-035551
Insider Transaction Report
Form 4
Babu Yarlagadda S
VP Drug Discovery
Transactions
- Award
Emp. Stock Option (Right to Buy)
2019-12-17+225,000→ 225,000 totalExercise: $3.23From: 2020-12-17Exp: 2029-12-17→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001452635
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:52 PM ET
- Size
- 5.1 KB